GoLiver Therapeutics is a spin-off of Inserm and the University of Nantes (CRTI UMR1064, ITUN, Nantes University Hospital). The company specializes in the development of Innovative Therapy Drugs (IMT) to meet an urgent unmet medical need in transplantation. It aims to become a major leader in regenerative medicine by tackling liver regeneration to treat liver disease without transplantation using differentiated pluripotent stem cells, globally.
Biotechnology, Health Care, Pharmaceutical
No funding announced yet
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as GoLiver Therapeutics? We’re happy to assist you with our Startup Sourcing service.